KPV is a short tripeptide fragment of α-MSH studied for anti-inflammatory effects. It is researched most often for Gut inflammation, Skin inflammation and Immune modulation. Preclinical research in inflammation models. This guide walks through what KPV is, how it's studied, what it's commonly combined with, and — just as important — where the science stops. It's educational information only, not medical advice.
What is KPV?
KPV is the C-terminal tripeptide of the alpha-melanocyte-stimulating hormone (α-MSH). Research has focused on its anti-inflammatory properties, particularly in the context of the gut and skin.
Also known as: Lysine-Proline-Valine, α-MSH 11-13.
How does KPV work?
KPV is the C-terminal tripeptide (lysine-proline-valine) of the hormone α-MSH. Research suggests it carries much of α-MSH's anti-inflammatory activity — potentially acting inside cells to dampen inflammatory signaling — which is why it is studied in gut and skin inflammation models.
What is KPV researched for?
In the research and community discussion, KPV comes up most often in connection with Gut inflammation, Skin inflammation and Immune modulation. Remember that "researched for" is not the same as "proven to treat" — these are the directions the science has explored, not established outcomes.
- Gut inflammation
- Skin inflammation
- Immune modulation
What does the research actually show?
Preclinical research in inflammation models. The honest framing matters here: promising mechanisms and early results are genuinely interesting, but they are not the same as proven, approved therapy. Anyone presenting KPV as a guaranteed treatment is getting ahead of the evidence.
What is KPV typically stacked with?
In the literature and community discussion, KPV is most often combined with BPC-157, based on complementary mechanisms. Selpho never provides dosing or protocols — combinations should only be considered with a licensed professional, since interactions and individual context matter.
Safety and considerations
Human clinical data is limited. Studied mostly in cell and animal models. Because the responsible framing is educational rather than prescriptive, Selpho provides no dosing, protocols, or purchase links, and always points back to a licensed professional for any decision. If you are dealing with a real health concern, that professional — not a peptide — is where planning should start.
Where to learn more about KPV
To go deeper, see the KPV library page for a quick reference; published research on PubMed; Selpho's free AI Peptide Advisor to see where KPV might fit your goals.
Frequently asked questions
Anti-inflammatory effects, particularly in the gastrointestinal tract and skin, plus general immune modulation. Evidence is mostly preclinical.
No. KPV is a small peptide fragment of α-MSH, not a corticosteroid. It is studied for anti-inflammatory activity through different pathways.
Human clinical data is limited; most research is in cell and animal models.
Not sure if KPV fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis guide is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.